Automate Your Wheel Strategy on DHR
With Tiblio's Option Bot, you can configure your own wheel strategy including DHR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DHR
- Rev/Share 33.5143
- Book/Share 73.0412
- PB 2.6993
- Debt/Equity 0.3316
- CurrentRatio 1.6194
- ROIC 0.0491
- MktCap 141176812320.0
- FreeCF/Share 6.7858
- PFCF 29.0368
- PE 41.3903
- Debt/Assets 0.2126
- DivYield 0.006
- ROE 0.0669
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | DHR | Scotiabank | Sector Perform | Sector Outperform | -- | $275 | July 11, 2025 |
| Upgrade | DHR | Barclays | Equal Weight | Overweight | -- | $205 | April 10, 2025 |
| Upgrade | DHR | Goldman | Neutral | Buy | -- | $260 | March 21, 2025 |
| Upgrade | DHR | Stifel | Hold | Buy | -- | $260 | March 14, 2025 |
| Downgrade | DHR | Raymond James | Outperform | Market Perform | -- | -- | Feb. 3, 2025 |
| Initiation | DHR | Scotiabank | -- | Sector Perform | -- | -- | Dec. 23, 2024 |
| Initiation | DHR | Guggenheim | -- | Buy | -- | $275 | Dec. 19, 2024 |
| Upgrade | DHR | BofA Securities | Neutral | Buy | -- | $290 | Dec. 13, 2024 |
| Initiation | DHR | Stephens | -- | Overweight | -- | $315 | Oct. 1, 2024 |
| Initiation | DHR | Wells Fargo | -- | Equal Weight | -- | $280 | Aug. 28, 2024 |
News
Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive
DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies. Softness in Life Sciences and Biotechnology units remains a concern.
Read More
Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript
Published: March 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Danaher Corporation (NYSE:DHR ) TD Cowen 45th Annual Health Care Conference Call March 5, 2025 10:30 AM ET Company Participants Rainer Blair – President and Chief Executive Officer Conference Call Participants Dan Brennan – TD Cowen Dan Brennan Welcome to day-three of the TD Cowen Global Healthcare Conference. I'm Dan Brennan, I follow tools and diagnostics.
Read More
Danaher Rewards Shareholders With 18.5% Dividend Increase
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
DHR's measures to consistently reward shareholders through dividends and share buybacks hold promise.
Read More
Industrial Laser Marking Machine Market To Reach USD 6.41 Billion by 2032, Growing at CAGR 8.1% | Coherent, Inc., Danaher Corporation, Epilog Laser
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
An industrial laser marking machine uses laser technology to engrave, etch, or mark materials with precision for identification, branding, or tracking. An industrial laser marking machine uses laser technology to engrave, etch, or mark materials with precision for identification, branding, or tracking.
Read More
3 Stocks Offering Strong Value and Stability
Published: February 24, 2025 by: MarketBeat
Sentiment: Positive
Though not as safe a bet as safe-haven assets like precious metals, value stocks are nonetheless an enticing option for investors when the market gets bumpy. An undervalued company that has excellent fundamentals but a less-than-stellar recent stock performance history is often better positioned to benefit during periods of volatility than growth names with less of a track record of success.
Read More
Danaher Announces Appointment of Charles Lamanna to Danaher Board
Published: February 20, 2025 by: PRNewsWire
Sentiment: Neutral
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Committee. Mr. Lamanna is currently Corporate Vice President, Business & Industry Copilot at Microsoft (NASDAQ: MSFT), where he drives product innovation in AI-powered business applications, low-code platforms, and autonomous agents.
Read More
Danaher: Self-Inflicted Pessimism?
Published: February 17, 2025 by: Seeking Alpha
Sentiment: Positive
Danaher Corp. has faced market punishment recently, but maintains strong margins and impressive FCF despite a tough year, indicating resilience and potential for future growth. The company's strategic capital allocation, including share buybacks and acquisitions, suggests management is positioning for long-term value creation, despite short-term pessimism. Danaher's bioprocessing segment shows consistent growth, and the upcoming patent cliff is expected to provide significant tailwinds, boosting demand for their life science equipment.
Read More
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Published: February 14, 2025 by: Seeking Alpha
Sentiment: Positive
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend stocks. Focused on wide-moat businesses, I prioritize quality and long-term growth over yield. My portfolio has outperformed the S&P 500, and I'm confident in its future. I expect a rotation to value stocks, and I'll keep sharing insights to grow together.
Read More
About Danaher Corporation (DHR)
- IPO Date 1978-12-29
- Website https://www.danaher.com
- Industry Medical - Diagnostics & Research
- CEO Rainer M. Blair
- Employees 61000